Successful Treatment of EBV PTLD with CNS Lymphomas with the Monoclonal Anti-CD20 Antibody Rituximab

Publisher： Karger

E-ISSN： 2296-5262|31|12|691-693

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.31, Iss.12, 2008-11, pp. : 691-693

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-CD20 Monoclonal Antibody (Rituximab) and Cidofovir as Successful Treatment of an EBV-Associated Lymphoma with CNS Involvement

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 491-494

Karger

Access to resources Recommend Favorite

Treatment of CNS Lymphoma with the Anti-CD20 Antibody Rituximab: Experience with Two Cases and Review of the Literature

By  

Oncology Research and Treatment, Vol. 26, Iss. 4, 2003-09 ,pp. : 351-354

Karger

Access to resources Recommend Favorite

Effective Treatment of Refractory Pulmonary Hemorrhage with Monoclonal Anti-CD20 Antibody (Rituximab)

By  

Respiration, Vol. 78, Iss. 1, 2008-09 ,pp. : 106-109

Karger

Access to resources Recommend Favorite

Rituximab (Anti-CD20 Monoclonal Antibody) Administration in a Young Patient with Resistant B-Prolymphocytic Leukemia

By  

Acta Haematologica, Vol. 102, Iss. 2, 1999-10 ,pp. : 94-98

Karger

Access to resources Recommend Favorite

Lymphomatoid Granulomatosis in a Patient with Rheumatoid Arthritis Receiving Methotrexate: Successful Treatment with the Anti-CD20 Antibody Mabthera

By  

Oncology Research and Treatment, Vol. 32, Iss. 7, 2009-06 ,pp. : 440-441

Karger

Access to resources Recommend Favorite